Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Dec 2024 value amounting to $63.2 million.

  • Phathom Pharmaceuticals' Shares Outstanding (Diluted Average) rose 13.57% to $73.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.4 million, marking a year-over-year increase of 13.57%. This contributed to the annual value of $63.2 million for FY2024, which is 23.18% up from last year.
  • According to the latest figures from FY2024, Phathom Pharmaceuticals' Shares Outstanding (Diluted Average) is $63.2 million, which was up 23.18% from $51.3 million recorded in FY2023.
  • Phathom Pharmaceuticals' Shares Outstanding (Diluted Average)'s 5-year high stood at $63.2 million during FY2024, with a 5-year trough of $39.1 million in FY2022.
  • In the last 3 years, Phathom Pharmaceuticals' Shares Outstanding (Diluted Average) had a median value of $51.3 million in 2023 and averaged $51.2 million.
  • Data for Phathom Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY surged of 31.11% (in 2023) over the last 5 years.
  • Phathom Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $39.1 million in 2022, then soared by 31.11% to $51.3 million in 2023, then grew by 23.18% to $63.2 million in 2024.